Myeloid IκBα Deficiency Promotes Atherogenesis by Enhancing Leukocyte Recruitment to the Plaques

Activation of the transcription factor NF-κB appears to be involved in different stages of atherogenesis. In this paper we investigate the role of NF-κB inhibitor IκBα in atherosclerosis. Myeloid-specific deletion of IκBα results in larger and more advanced lesions in LDL-R-deficient mice without affecting the compositional phenotype of the plaques or systemic inflammatory markers in the plasma. We show that IκBα-deleted macrophages display enhanced adhesion to an in vitro endothelial cell layer, coinciding with an increased expression of the chemokine CCL5. Also, in vivo we found that IκBαdel mice had more leukocytes adhering to the luminal side of the endothelial cell layers that cover the atherosclerotic plaques. Moreover, we introduce ER-MP58 in this paper as a new immunohistochemical tool for quantifying newly recruited myeloid cells in the atherosclerotic lesion. This staining confirms that in IκBαdel mice more leukocytes are attracted to the plaques. In conclusion, we show that IκBα deletion in myeloid cells promotes atherogenesis, probably through an induced leukocyte recruitment to plaques.

[1]  I. van der Made,et al.  Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. , 2010, Cell metabolism.

[2]  Soo-Ho Choi,et al.  Low Doses of Lipopolysaccharide and Minimally Oxidized Low-Density Lipoprotein Cooperatively Activate Macrophages via Nuclear Factor &kgr;B and Activator Protein-1: Possible Mechanism for Acceleration of Atherosclerosis by Subclinical Endotoxemia , 2010, Circulation research.

[3]  A. Zernecke,et al.  Chemokines in the vascular inflammatory response of atherosclerosis. , 2010, Cardiovascular research.

[4]  K. Moore,et al.  CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer , 2009, Nature Immunology.

[5]  M. Karin,et al.  Regulation and function of NF-kappaB transcription factors in the immune system. , 2009, Annual review of immunology.

[6]  G. Kollias,et al.  Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. , 2008, Cell metabolism.

[7]  Christian Weber,et al.  Chemokines in Atherosclerosis , Thrombosis , and Vascular Biology Series Editor : Christian Weber Chemokines in Atherosclerosis An Update , 2008 .

[8]  G. Natoli,et al.  Nuclear Ubiquitin Ligases, NF-κB Degradation, and the Control of Inflammation , 2008, Science Signaling.

[9]  D. Teupser,et al.  The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-κB target genes , 2007, Proceedings of the National Academy of Sciences.

[10]  M. Flaig,et al.  Crosstalk between Keratinocytes and Adaptive Immune Cells in an IκBα Protein-Mediated Inflammatory Disease of the Skin , 2007 .

[11]  S. Gerondakis,et al.  Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models , 2006, Oncogene.

[12]  A. Tedgui,et al.  Cytokines in atherosclerosis: pathogenic and regulatory pathways. , 2006, Physiological reviews.

[13]  S. Xanthoulea,et al.  Nuclear factor kappaB signaling in macrophage function and atherogenesis , 2005, Current opinion in lipidology.

[14]  I. Verma,et al.  Distinct roles of IκB proteins in regulating constitutive NF-κB activity , 2005, Nature Cell Biology.

[15]  M. Hofker,et al.  Nuclear Factor &kgr;B Signaling in Atherogenesis , 2005 .

[16]  B. Dörken,et al.  Stroma-Mediated Dysregulation of Myelopoiesis in Mice Lacking IκBα , 2005 .

[17]  N. Cheshire,et al.  Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  N. Van Rooijen,et al.  Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response1 , 2004, The Journal of Immunology.

[19]  J. Hamilton,et al.  The Phenotype of Inflammatory Macrophages Is Stimulus Dependent: Implications for the Nature of the Inflammatory Response1 , 2003, The Journal of Immunology.

[20]  Georg Kraal,et al.  Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. , 2003, The Journal of clinical investigation.

[21]  M. Cybulsky,et al.  The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[23]  S. Nishikawa,et al.  Macrophage lineage cells in inflammation: characterization by colony-stimulating factor-1 (CSF-1) receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) expression. , 1998, Blood.

[24]  F. Neumann,et al.  Dysregulation of Monocytic Nuclear Factor-κB by Oxidized Low-Density Lipoprotein , 1997 .

[25]  H. Kiwada,et al.  Repopulation of murine Kupffer cells after intravenous administration of liposome-encapsulated dichloromethylene diphosphonate. , 1996, American Journal of Pathology.

[26]  C. Stewart,et al.  IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice , 1996, Molecular and cellular biology.

[27]  R. Knuechel,et al.  Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. , 1996, The Journal of clinical investigation.

[28]  D. Baltimore,et al.  Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. , 1995, Genes & development.

[29]  M. D. de Bruijn,et al.  Markers of mouse macrophage development detected by monoclonal antibodies. , 1994, Journal of immunological methods.

[30]  M. Flaig,et al.  Crosstalk between keratinocytes and adaptive immune cells in an IkappaBalpha protein-mediated inflammatory disease of the skin. , 2007, Immunity.

[31]  B. Dörken,et al.  Stroma-mediated dysregulation of myelopoiesis in mice lacking I kappa B alpha. , 2005, Immunity.

[32]  I. Verma,et al.  Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. , 2005, Nature cell biology.

[33]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[34]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[35]  H. Pahl,et al.  Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.

[36]  F. Neumann,et al.  Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein. , 1997, Arteriosclerosis, thrombosis, and vascular biology.